Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 19.7% | 20.4% | 24.0% | 22.2% | 26.5% | 25.7% | 26.0% | 29.0% | 30.3% | 32.5% | 57.2% | 1,143.9% | (231.1%) | (324.9%) | (1,195.6%) | 507.5% | 143.6% | 112.6% | 104.6% | 80.7% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 31.4%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for IDEXX Laboratories, Inc. have been 87.2% over the past three years, and 121.4% over the past five years.
As of today, IDEXX Laboratories, Inc.'s Return on Equity (ROE) is 31.4%, which is higher than industry median of (16.4%). It indicates that IDEXX Laboratories, Inc.'s Return on Equity (ROE) is Good.